Corcept Therapeutics Incorporated - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CORT Nasdaq 2830 www.corcept.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Corcept Therapeutics Incorporated

Corcept Therapeutics Lawsuits And CRL Put Relacorilant Story Under Pressure - Feb 27th, 2026 8:10 am
Is Corcept Therapeutics (CORT) Pricing Reflect Its Sharp One Year Share Price Decline - Feb 27th, 2026 7:12 am
Corcept Therapeutics Incorporated Q4 2025 Earnings Call Summary - Feb 25th, 2026 6:03 pm
Corcept Therapeutics Inc (CORT) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges - Feb 24th, 2026 10:01 pm
Corcept Therapeutics Q4 Earnings Call Highlights - Feb 24th, 2026 9:11 pm
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates - Feb 24th, 2026 7:55 pm
Corcept: Q4 Earnings Snapshot - Feb 24th, 2026 3:13 pm
Corcept (NASDAQ:CORT) Misses Q4 CY2025 Sales Expectations - Feb 24th, 2026 2:49 pm
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update - Feb 24th, 2026 2:05 pm
Is Corcept Therapeutics Incorporated (CORT) at an inflection point? - Feb 24th, 2026 6:06 am
Corcept (CORT) Q4 Earnings: What To Expect - Feb 22nd, 2026 8:12 pm
Stock Market Today, Feb. 19: Rising Geopolitical Tensions Weigh on Markets - Feb 19th, 2026 3:36 pm
Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals - Feb 19th, 2026 2:00 pm
A Look At Corcept Therapeutics (CORT) Valuation After FDA Complete Response Letter For Relacorilant - Feb 19th, 2026 1:21 am
How Investors May Respond To Corcept Therapeutics (CORT) FDA CRL And New Securities-Law Probes - Feb 18th, 2026 12:12 pm
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call - Feb 17th, 2026 2:05 pm
3 Small-Cap Stocks We Think Twice About - Feb 16th, 2026 9:35 pm
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT) - Feb 16th, 2026 10:24 am
3 Cash-Producing Stocks We’re Skeptical Of - Feb 15th, 2026 9:34 pm
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know - Feb 13th, 2026 1:51 pm